Recurrent Rectal Cancer Recruiting Phase 1 Trials for Fluorouracil (DB00544)

Also known as: Rectal cancer recurrent / Carcinoma rectum recurrent / Rectal carcinoma recurrent / Carcinoma of rectum recurrent

IndicationStatusPhase
DBCOND0028583 (Recurrent Rectal Cancer)Recruiting1
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT02232152CPI-613 and Fluorouracil in Treating Patients With Metastatic Colorectal Cancer That Cannot Be Removed by SurgeryTreatment